Stock Analysis 2026

Jefferies and Mizuho Elevate Price Targets for Williams Companies Amid Robust Growth Prospects

by
Williams Companies stock chart showing upward trend with analyst target icons

***”Analysts at Jefferies and Mizuho have upgraded their price targets for Williams Companies (WMB), signaling confidence in the firm’s expanding natural gas infrastructure and potential for accelerated EBITDA growth. The moves reflect optimism around power sector opportunities and strategic asset expansions, with the stock demonstrating resilience in a volatile energy market.”*** Williams Companies, a leading … Read more

Haemonetics Delivers Robust Q3 Performance Amid Strategic Adjustments

by
Haemonetics Corporation headquarters building with company logo

“Haemonetics reported third-quarter fiscal earnings with revenue of $339 million and adjusted earnings per share of $1.31, surpassing analyst expectations. Key segments showed mixed results, with Plasma up 3.5% and Blood Center down 19.6% due to divestitures. The company raised its full-year guidance, projecting adjusted EPS between $4.90 and $5.00 alongside improved organic growth forecasts.” … Read more

IonQ Inc (IONQ) Strengthening Itself Through Acquisitions

by
Illustration depicting IonQ's quantum technology stack enhanced by strategic acquisitions

“IonQ Inc has aggressively pursued acquisitions in 2025 and 2026 to enhance its quantum computing ecosystem, including deals for Skyloom Global, Seed Innovations, SkyWater Technology, Vector Atomic, Capella Space, Oxford Ionics, ID Quantique, Lightsynq, and Qubitekk, focusing on networking, software, manufacturing, and precision technologies to achieve vertical integration and market leadership.” IonQ Inc, a frontrunner … Read more

Jim Cramer Deems Lithium Americas Too Speculative Amid Surging Market Dynamics

by
Jim Cramer analyzing lithium stocks on financial news program

“Jim Cramer cautions investors on Lithium Americas, labeling it overly speculative due to market volatility and project risks, while favoring established players like Albemarle as lithium demand surges from EVs and energy storage.” Jim Cramer on Lithium Americas: “We’re Going to Say It’s Too Speculative for Me” In a recent episode of his popular financial … Read more

Scotiabank Notes Bristol-Myers Squibb Company (BMY) as Appealing Investment in 2026

by
Graph illustrating Bristol-Myers Squibb stock valuation and 2026 catalysts

Scotiabank has raised its price target for Bristol-Myers Squibb (BMY) to $60, citing the company’s low valuation and a catalyst-rich year ahead in 2026, driven by advancements in its oncology and immunology pipeline, delayed patent cliffs, and strong financial positioning that positions it for potential outperformance in the pharmaceutical sector. Bristol-Myers Squibb stands out in … Read more